GMP News
14 September 2005
|
|
Revision
of USP Chapter <1116>
on Environmental Monitoring
|
The informal Chapter <1116> of the US-American Pharmacopoeia (USP), "Microbiological Evaluation of Clean
Rooms and Other Controlled Environments", is currently being revised
- a process that started in spring this year.
The draft of the revision is quite fundamental, which can be seen from
the fact that the title was changed to "Microbiological
Controls and Monitoring Environments used for the Manufacture of
Healthcare Products".
The driving force behind the changes was certainly the replacement of
the former cleanroom classes defined in US Federal Standard 209e by ISO
Standard 14644. Furthermore, the new state of the art will be taken into
account in the revised version.
In the following we have compiled the changes in the titles of the
subchapters for you.
- Establishment of Clean Room Classifications (title
unchanged)
- Importance of a Microbiological Evaluation Program for Controlled
Environments (title unchanged)
- Physical Evaluation of Contamination Control Effectiveness (new
subchapter)
- Training of Personnel (title unchanged)
- Critical Factors Involved in the Design and Implementation of a
Microbiological Environmental Control Program (title unchanged)
- Establishment of Sampling Plan and Sites (title unchanged)
- Establishment of Microbiological Alert and Action Levels in
Controlled Environments (title changed to "Selection of Sample Sites within Clean Rooms and Aseptic
Processing Areas")
- Microbial Considerations and Action Levels for Controlled
Environments (title changed to "Establishment of Microbiological Control Parameters in Clean
Rooms and Isolators Used for Aseptic Processing")
- Methodology and Instrumentation for Quantitation of Viable Airborne
Microorganisms (title changed to
"Methodology and Instrumentation for Sampling of Airborne
Microorganisms")
- Sample Volumes For Active Air Monitoring (new
subchapter)
- Methodology and Equipment for Sampling of Surfaces for Quantitation
of Viable Microbial Contaminations in Controlled Environments (title unchanged)
- Culture Media and Diluents for Sampling or Quantitation (title
changed to "Culture Media and Diluents Used for Sampling")
- Identification of Microbial Isolates from the Environmental Control
Program (title unchanged)
- Operational Evaluation of the Microbiological Status of Aseptically
Filled Products in Clean Rooms and Other Controlled Environments (deleted)
- An Overview of the Emerging Technologies for Advanced Aseptic
Processing (deleted)
- Conclusion (new subchapter)
- Glossary (title unchanged)
The scope of changes varies from chapter to chapter. The following
areas have undergone considerable extension
- the suggestions on sampling frequency in aseptic production units
- the requirements on personnel training
- advice on monitoring in isolators
|
At the following events, you will get detailed information about the
current requirements on environmental monitoring in aseptic manufacture:
- Complying with the
New FDA Aseptic Guide, Berlin, Germany, 29-30 September 2005
- Microbiological Contamination
in Pharmaceutical Production, Barcelona, Spain,
20-21 October 2005
- Cleanrooms (With a guided tour through the NovoSeven Facility),
Copenhagen, Denmark,
8-9 November 2005
- Microbiological Challenges for GMP/FDA Compliance - Masterclass -, Berlin, Germany,
23-25 November 2005
- Environmental
Monitoring - Compliant and Reasonable, Copenhagen, Denmark,
18-19
May 2006
|
Author:
Dr Andreas Mangel
on behalf of ECA
|
|
|
|